Rather a lot of us suffer from high blood pressure, and stories like this don’t make us feel any better:
For the third time in recent weeks, a blood pressure medication has been recalled because it may have been contaminated with an agent linked to cancer.
Sandoz, a generic pharmaceutical company that’s a division of the Novartis Group, said it’s voluntarily recalled losartan potassium hydrochlorothiazide tablets because the pills could contain the impurity N-nitrosodiethylamine (NDEA).
Sandoz said the tablets are manufactured by Lek Pharmaceuticals in Slovenia and the impurity found is a probable carcinogen. However, it said, no issues have been reported concerning the affected tablets.
How times have changed. If you’re around my age, you may remember Sandoz as the developer of LSD, which was first marketed as a treatment for various mental ailments in 1947 under the name “Delysid.” Timothy Leary, at Harvard in the 1960s, began promoting the stuff for, um, nonprescription use. (Eric Burdon’s New Animals dropped a tune called “A Girl Named Sandoz” on the B-side of “When I Was Young”; it fooled no one.)
As it happens, this is the antihypertensive I take, though the stock I have on the shelf did not originate with Sandoz or its suppliers.